Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up. results from the danbio registry

Details

Database :

OAIster

Journal :

Glintborg , B , Sørensen , IJ , Loft , AG , Esbesen , J , Lindegaard , H , Jensen , DV , Danebod , K , Dieperink , S , Hendricks , O , Hansen , IMJ , Linauskas , A , Kristensen , S , Andersen , LS , Hossein , M , Nordin , H , Andersen , BL , Chrysidis , S , Raun , JL , Manilo , N , Grydehøj , J , Dalgaard , EB , Pedersen , DD , Krogh , NS & Hetland , ML 2017 , ' Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up. results from the danbio registry ' , Annals of the Rheumatic Diseases , vol. 76 , no. Suppl 2 , FRI0190 , pp. 553-554 .

Notes :

English

Publication Type :

Electronic Resource

Accession number :

edsoai.on1322710746

Document Type :

Electronic Resource